상세 보기
IEEE Transactions on Nanobioscience
ISSN
P 1536-1241 E 1558-2639
출판사
Institute of Electrical and Electronics Engineers IEEE
국가
USA
발행 상태
활성
데이터베이스 수록 정보
EMBASE 2016-2020 (5년)
JCR 2005-2019 (15년)
MEDLINE 2016-2021 (6년)
SCIE 2010-2021 (12년)
Scopus 2017-2020 (4년)
SJR 2003-2019 (17년)
전체 23건 중 1번부터 10번까지의 결과를 표시합니다.
2025
Article
Real-world evidence of first-or second-line immune checkpoint inhibitors versus chemotherapy in advanced NSCLC: A prospective pragmatic multicenter Korean study
- Kim, J. ;
- Park, S. ;
- Lee, G- W. ;
- Kim, I. H. ;
- Kim, D- W. ;
- 외 12명
- 2025-12
- Annals of Oncology
- Oxford University Press
Article
A multi-center, randomized, double-blind, placebo-controlled, therapeutic exploratory, phase II clinical trial for the efficacy investigation and safety evaluation of DWP708 for treating epidermal growth factor receptor inhibitor related skin toxicities
- Kim, H. R. ;
- Kang, J. H. ;
- Kim, S. T. ;
- Kim, C. K. ;
- Hwang, I. G. ;
- 외 11명
- 2025-09
- Annals of Oncology
- Oxford University Press
2024
Article
Exploratory biomarker analysis in EGFR mutated NSCLC patients who treated with atezolizumab plus bevacizumab and chemotherapy from phase III ATTLAS trial
- Kim, H. ;
- Park, S. ;
- Kim, T. M. ;
- Han, J-Y. ;
- Lee, G-W. ;
- 외 12명
- 2024-12
- Annals of Oncology
- Oxford University Press
Article
Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab (KCSG HB23-04)
- Yoo, C. ;
- Kim, H-D. ;
- Chon, H. J. ;
- Sym, S. J. ;
- Kim, M. ;
- ... Kang, J. H. ;
- 외 9명
- 2024-12
- Annals of Oncology
- Oxford University Press
Article
Erlotinib plus bevacizumab in patients with metastatic solid tumors with EGFR amplification: Results from the KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced solid tumors, KCSG AL 22-09)
- Lee, J. W. ;
- Lee, Y-g. ;
- Lee, G-W. ;
- Jung, H. A. ;
- Kim, K-p. ;
- 외 12명
- 2024-12
- Annals of Oncology
- Oxford University Press
2023
Article
Phase III study of telisotuzumab vedotin (Teliso-V) vs docetaxel in pretreated c-Met overexpressing EGFR wildtype (WT) non-squamous (NSQ) locally advanced/ metastatic nonsmall cell lung cancer (a/mNSCLC)
- Tanizaki, J. ;
- Akamatsu, H. ;
- Su, J. ;
- Lee, G-W. ;
- Xia, M. S. ;
- 외 5명
- 2023-11
- Annals of Oncology
- Oxford University Press
Article
Advantig-105: Phase Ib dose-expansion study of ociperlimab (OCI) plus tislelizumab (TIS) with chemotherapy (CT) in patients (pts) with metastatic oesophageal squamous cell carcinoma (ESCC) and oesophageal adenocarcinoma (EAC)
- Sun, M. ;
- Spigel, D. R. ;
- Lee, Y-J. ;
- Yoon, H. ;
- Liu, Y. ;
- ... Lee, G-W. ;
- 외 11명
- 2023-10
- Annals of Oncology
- Oxford University Press
Article
Final clinical outcomes of nationwide precision oncology pilot study; KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS) KCSG AL-20-05
- Kim, T-y. ;
- Kim, S. Y. ;
- Kim, J. H. ;
- Jung, H. A. ;
- Choi, Y. J. ;
- ... Lee, G-W. ;
- 외 14명
- 2023-10
- Annals of Oncology
- Oxford University Press
Article
Morphine titration with intravenous patient-controlled analgesia for severe cancer pain (Mr.TIPS)
- Huh, S. J. ;
- Oh, S. Y. ;
- Kang, J. H. ;
- Go, S-I. ;
- Lee, S. ;
- 외 1명
- 2023-10
- Annals of Oncology
- Oxford University Press
Article
A phase III, randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04)
- Ahn, M. J. ;
- Park, S. ;
- Kim, T. M. ;
- Han, J. Y. ;
- Lee, G. W. ;
- 외 12명
- 2023-10
- Annals of Oncology
- Oxford University Press
1